3 Timeless Lessons Every Investor Can Learn From Valeant Pharmaceuticals’ Crash

Valeant Pharmaceuticals plunged more than 45% after the once high-flying Canadian biotech company reported earnings, slashed guidance and warned of a potential default. There are many important lessons investors can learn (or relearn) from the collapse in $VRX and I will cover three of them today.

Week In Review: Bull Market Turns 7: Rally Continues On Wall Street

Stocks rallied nicely last week but it was another volatile week. The moves that are occurring in capital markets are wild. In fact, they are some of the largest moves (both up and down) we have seen in years. The wild moves are taking place across several asset classes with some of the largest swings…

Buy The Rumor, Sell The News: Draghi’s Bazooka Fires A Blank

Buy The Rumor, Sell The News: Draghi’s Bazooka Fires A Blank

Today, I’m reminded of the old Wall Street adage: Buy The Rumor, Sell The News. On average, capital markets are a forward looking mechanism and tend to discount future events. So they tend to rally into a major event then sell off when the event actually occurs. We have seen tremendous moves in global markets…